Key regions: Australia, United States, India, Europe, China
The Digestive & Intestinal Remedies (Pharmacies) market in Northern Africa is experiencing significant growth due to changing customer preferences and trends in the market. Customer preferences in the Digestive & Intestinal Remedies (Pharmacies) market in Northern Africa have shifted towards natural and herbal remedies. Customers are increasingly seeking products that are derived from natural ingredients and have minimal side effects. This preference for natural remedies is driven by a growing awareness of the potential health risks associated with synthetic pharmaceuticals. As a result, there has been a rise in the demand for herbal remedies and traditional medicines in the region. Trends in the market indicate a growing focus on digestive health and wellness. Customers are becoming more conscious of their digestive health and are actively seeking products that can help alleviate digestive issues. This trend is fueled by changing dietary habits, sedentary lifestyles, and an increase in stress levels. As a result, there has been a surge in the demand for products such as probiotics, digestive enzymes, and fiber supplements. Local special circumstances in Northern Africa also contribute to the growth of the Digestive & Intestinal Remedies (Pharmacies) market. The region has a high prevalence of gastrointestinal disorders, including irritable bowel syndrome, acid reflux, and constipation. These conditions are often attributed to factors such as poor diet, lack of physical activity, and stress. The high incidence of digestive disorders has created a significant market opportunity for companies offering remedies and treatments for these conditions. Underlying macroeconomic factors further support the growth of the Digestive & Intestinal Remedies (Pharmacies) market in Northern Africa. The region has been experiencing economic growth, resulting in an increase in disposable income and improved access to healthcare services. As a result, consumers are more willing to spend on healthcare products, including digestive remedies. Additionally, the growing middle class in the region has led to an expansion of the healthcare sector, including an increase in the number of pharmacies and healthcare facilities. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Northern Africa is developing due to changing customer preferences towards natural remedies, a focus on digestive health and wellness, local special circumstances, and underlying macroeconomic factors. As the market continues to grow, companies in the region have an opportunity to cater to the evolving needs of customers and capitalize on the increasing demand for digestive remedies.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
